Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis

Health and Quality of Life Outcomes

Volumn 11, Issue 1, 2013, Pages

  ten Klooster, Peter M ^a   Vonkeman, Harald E ^a,b   Taal, Erik ^a   Siemons, Liseth ^a   Hendriks, Lidy ^c   de Jong, Alphons J L ^d   Dutmer, Ellen A J ^e   van Riel, Piet L C M ^f   van de Laar, Mart A F J ^a,b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

^e GELDERSE VALLEI HOSPITAL   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CONSTRUCT VALIDITY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HEALTH; HEALTH SURVEY; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; QUALITY OF LIFE; RATING SCALE; RELIABILITY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHORT FORM 36; SOCIAL INTERACTION;

ADULT; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMETRICS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; REPRODUCIBILITY OF RESULTS;

EID: 84877877491     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-11-77     Document Type: Article

References (50)

1. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002, 1593914.
2. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 2002, 324:1417. 10.1136/bmj.324.7351.1417, 115850, 12065262.
3. Busija L, Pausenberger E, Haines TP, Haymes S, Buchbinder R, Osborne RH. Adult measures of general health and health-related quality of life: medical outcomes study short form 36-item (SF-36) and short form 12-item (SF-12) health surveys, nottingham health profile (NHP), sickness impact profile (SIP), medical outcomes study short form 6D (SF-6D), health utilities index mark 3 (HUI3), quality of well-being scale (QWB), and assessment of quality of life (AQOL). Arthritis Care Res 2011, 63:S383-S412.
4. Kalyoncu U, Dougados M, Daures JP, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2009, 68:183-190. 10.1136/ard.2007.084848, 18375533.
5. Birrell FN, Hassell AB, Jones PW, Dawes PT. How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study. Clin Rheumatol 2000, 19:195-199. 10.1007/s100670050155, 10870653.
6. Koh ET, Leong KP, Tsou IY, Lim VH, Pong LY, Chong SY, Seow A. The reliability, validity and sensitivity to change of the Chinese version of SF-36 in oriental patients with rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:1023-1028.
7. Kosinski M, Keller SD, Hatoum HT, Kong SX, Ware JE. The SF-36 health survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability. Med Care 1999, 37:MS10-MS22.
8. Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008, 35:1528-1537.
9. Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the norwegian SF-36 health survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol 1998, 51:1069-1076. 10.1016/S0895-4356(98)00098-5, 9817124.
10. Ruta DA, Hurst NP, Kind P, Hunter M, Stubbings A. Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol 1998, 37:425-436. 10.1093/rheumatology/37.4.425, 9619895.
11. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993, 118:622-629. 10.7326/0003-4819-118-8-199304150-00009, 8452328.
12. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989, 27:S217-S232. 10.1097/00005650-198903001-00018, 2646490.
13. Hagen KB, Smedstad LM, Uhlig T, Kvien TK. The responsiveness of health status measures in patients with rheumatoid arthritis: comparison of disease-specific and generic instruments. J Rheumatol 1999, 26:1474-1480.
14. Veehof MM, ten Klooster PM, Taal E, van Riel PL, van de Laar MA. Comparison of internal and external responsiveness of the generic medical outcome study short form-36 (SF-36) with disease-specific measures in rheumatoid arthritis. J Rheumatol 2008, 35:610-617.
15. Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, Dorrier C, Thompson A. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide rheumatoid arthritis investigators group. Arthritis Rheum 2000, 43:506-514. 10.1002/1529-0131(200003)43:3<506::AID-ANR5>3.0.CO;2-U, 10728742.
16. Ware JE. SF-36 health survey update. Spine 2000, 25:3130-3139. 10.1097/00007632-200012150-00008, 11124729.
17. Ware JE, Kosinski M, Dewey JE. How to score version 2 of the SF-36 health survey 2000, Lincoln, RI: QualityMetric Incorporated.
18. Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 1999, 53:46-50. 10.1136/jech.53.1.46, 1756775, 10326053.
19. Taft C, Karlsson J, Sullivan M. Performance of the Swedish SF-36 version 2.0. Qual Life Res 2004, 13:251-256.
20. Kievit W, Fransen J, Oerlemans AJ, Kuper HH, van de Laar MA, de Rooij DR, De Gendt CM, Ronday KH, Jansen TL, van Oijen PC. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomized controlled trials and clinical practice. Ann Rheum Dis 2007, 66:1473-1478. 10.1136/ard.2007.072447, 2111629, 17426065.
21. Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, van Riel PL, van de Laar MA. Implementation of a treat to target strategy in very early rheumatoid arthritis: results of the DREAM remission induction cohort. Arthritis Rheum 2011, 6:2865-2872.
22. Bullinger M, Alonso J, Apolone G, Leplege A, Sullivan M, Wood-Dauphinee S, Gandek B, Wagner A, Aaronson N, Bech P. Translating health status questionnaires and evaluating their quality: the IQOLA project approach. International quality of life assessment. J Clin Epidemiol 1998, 51:913-923. 10.1016/S0895-4356(98)00082-1, 9817108.
23. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
24. Gestel VAM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998, 41:1845-1850. 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K, 9778226.
25. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982, 9:789-793.
26. ten Klooster PM, Taal E, van de Laar MA. Rasch analysis of the dutch health assessment questionnaire disability index and the health assessment questionnaire II in patients with rheumatoid arthritis. Arthritis Rheum 2008, 59:1721-1728. 10.1002/art.24065, 19035413.
27. Ware JE, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA project approach. International quality of life assessment. J Clin Epidemiol 1998, 51:945-952. 10.1016/S0895-4356(98)00085-7, 9817111.
28. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-263. 10.1097/00005650-199303000-00006, 8450681.
29. Fayers PM, Machin D. Scores and measurements: validity, reliability, sensitivity. Quality of Life: the assessment, analysis and interpretation of patient-reported outcomes 2007, 77-108. Chichester: John Wiley & Sons, Fayers PM, Machin D, 2.
30. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000, 53:459-468. 10.1016/S0895-4356(99)00206-1, 10812317.
31. Cohen J. Statistical power analysis for the behavioural sciences 1988, Hillsdale, NJ: Lawrence Erlbaum Associates, 2.
32. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E. Translation, validation, and norming of the dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998, 51:1055-1068. 10.1016/S0895-4356(98)00097-3, 9817123.
33. Schröder A, Oernboel E, Licht RW, Sharpe M, Fink P. Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid. J Clin Epidemiol 2012, 65:30-41. 10.1016/j.jclinepi.2011.03.012, 21764558.
34. Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 2006, 45:885-889.
35. Belza BL. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol 1995, 22:639-643.
36. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996, 23:1407-1417.
37. Hobart JC, Williams LS, Moran K, Thompson AJ. Quality of life measurement after stroke: uses and abuses of the SF-36. Stroke 2002, 33:1348-1356. 10.1161/01.STR.0000015030.59594.B3, 11988614.
38. Hann M, Reeves D. The SF-36 scales are not accurately summarised by independent physical and mental component scores. Qual Life Res 2008, 17:413-423. 10.1007/s11136-008-9310-0, 18259888.
39. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R. The american college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993, 36:729-740. 10.1002/art.1780360601, 8507213.
40. Fransen J, van Riel PL. Outcome measures in inflammatory rheumatic diseases. Arthritis Res Ther 2009, 11:244. 10.1186/ar2745, 2787283, 19849821.
41. Vander Cruyssen B, Van Looy S, Wyns B, Westhovens R, Durez P, Van den Bosch F, Veys EM, Mielants H, De Clerck L, Peretz A. DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. Arthritis Res Ther 2005, 7:R1063-R1071. 10.1186/ar1787, 1257436, 16207323.
42. Bruce B, Fries JF. The stanford health assessment questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003, 1:20. 10.1186/1477-7525-1-20, 165587, 12831398.
43. Ten Klooster PM, Oude Voshaar MA, Taal E, van de Laar MA. Comparison of measures of functional disability in patients with gout. Rheumatology (Oxford) 2011, 50:709-713.
44. Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998, 51:1077-1086. 10.1016/S0895-4356(98)00099-7, 9817125.
45. Oude Voshaar MA, ten Klooster PM, Taal E, van de Laar MA. Measurement properties of physical function scales validated for use in patients with rheumatoid arthritis: A systematic review of the literature. Health Qual Life Outcomes 2011, 9:99. 10.1186/1477-7525-9-99, 3221621, 22059801.
46. Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ 1992, 305:1145-1148. 10.1136/bmj.305.6862.1145, 1883654, 1463954.
47. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 2010, 63:1179-1194. 10.1016/j.jclinepi.2010.04.011, 2965562, 20685078.
48. Hawthorne G, Osborne RH, Taylor A, Sansoni J. The SF36 version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res 2007, 16:661-673. 10.1007/s11136-006-9154-4, 17268926.
49. Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, Joseph L, Brown JP, Murray TM, Adachi JD. Canadian normative data for the SF-36 health survey. Canadian multicentre osteoporosis study research group. CMAJ 2000, 163:265-271. 80287, 10951722.
50. Scott KM, Tobias MI, Sarfati D, Haslett SJ. SF-36 health survey reliability, validity and norms for New Zealand. Aust N Z J Public Health 1999, 23:401-406. 10.1111/j.1467-842X.1999.tb01282.x, 10462864.